Finance

Lists
Why is PROK down 5,99%?
Dive Deeper
PROK:NASDAQ
ProKidney Corp
USD 1,57
-5,99%
(-0,100) 1D
USD 1,56
-0,64% (-0,010)
After hours
Closed: 13 Okt., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PROK...
Open
USD 1,65
High
USD 1,68
Low
USD 1,53
Mkt. cap
474,65 m
Avg. vol.
1,50 m
Volume
1,60 m
52-wk high
USD 3,48
52-wk low
USD 1,30
EPS
-USD 0,55
Beta
1,78
Shares outstanding
208,93 m
No. of employees
231
Open
USD 1,65
High
USD 1,68
Low
USD 1,53
Mkt. cap
474,65 m
Avg. vol.
1,50 m
Volume
1,60 m
52-wk high
USD 3,48
52-wk low
USD 1,30
EPS
-USD 0,55
Beta
1,78
Shares outstanding
208,93 m
No. of employees
231
News stories
From web sources and news partners
About ProKidney Corp
CEO-
Employees231
Founded2015
HeadquartersWinston-Salem, Noord-Carolina, Verenigde State van Amerika
Sector-
Websiteprokidney.com
Analyst ratings
Based on 5 analysts giving stock ratings to PROK in the past 3 months
Hold
Buy
2
Hold
2
Sell
1
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for PROK in the last 3 months.
Highest
Current USD 1,57
USD 12,00 (+664,33%)
Average
USD 5,75 (+266,24%)
Lowest
USD 1,00 (-36,31%)
Analyst
Recommendation
Action
Price target
Projected
Date
Dina Ramadane
Bank of America Securities
Sell
Maintained
USD 1,00
-36,3%
10/12/2026
Anupam Rama
J.P. Morgan
Hold
Maintained
-
-
08/13/2026
Judah Frommer
Morgan Stanley
Hold
Maintained
USD 3,00
+91,1%
08/11/2026
Unknown Analyst
Guggenheim
Buy
Maintained
USD 7,00
+345,9%
08/10/2026
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
USD 12,00
+664,3%
08/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
217,00 k
225,00 k
226,00 k
150,00 k
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
26,82 m
34,16 m
33,84 m
36,10 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,62 m
11,76 m
11,32 m
12,43 m
Operating expense
38,44 m
45,91 m
45,16 m
48,52 m
Total operating expenses
38,44 m
45,91 m
45,16 m
48,52 m
Operating income
-38,22 m
-45,69 m
-44,93 m
-48,37 m
Other non operating income
-
-
-
-
EBT including unusual items
-35,28 m
-42,44 m
-42,62 m
-46,44 m
EBT excluding unusual items
-34,96 m
-42,76 m
-42,62 m
-46,44 m
Income tax expense
560,00 k
-1,58 m
-
-
Effective tax rate
-1,59%
3,73%
-
-
Other operating expenses
-
-
-
-
Net income
-16,47 m
-19,23 m
-20,04 m
-28,42 m
Net profit margin
-7 589,40%
-8 547,11%
-8 865,93%
-18 948,00%
Earnings per share
-0,12
-0,14
-0,14
-0,15
Interest and investment income
3,26 m
2,94 m
2,33 m
1,94 m
Interest expense
-2,00 k
-1,00 k
-15,00 k
-1,00 k
Net interest expenses
3,26 m
2,93 m
2,31 m
1,94 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-36,55 m
-43,85 m
-43,28 m
-46,70 m
Gain or loss from assets sale
10,00 k
957,00 k
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme